Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Cash from Discontinued Operations: 2016-2018

Historic Cash from Discontinued Operations for Soleno Therapeutics (SLNO) over the last 2 years, with Dec 2018 value amounting to -$188,000.

  • Soleno Therapeutics' Cash from Discontinued Operations rose 66.61% to -$188,000 in Q4 2018 from the same period last year, while for Dec 2018 it was -$1.4 million, marking a year-over-year increase of 55.10%. This contributed to the annual value of -$1.4 million for FY2018, which is 55.10% up from last year.
  • As of Q4 2018, Soleno Therapeutics' Cash from Discontinued Operations stood at -$188,000, which was up 53.58% from -$405,000 recorded in Q3 2018.
  • In the past 5 years, Soleno Therapeutics' Cash from Discontinued Operations registered a high of -$188,000 during Q4 2018, and its lowest value of -$2.8 million during Q3 2016.
  • Moreover, its 3-year median value for Cash from Discontinued Operations was -$648,000 (2017), whereas its average is -$855,927.
  • Data for Soleno Therapeutics' Cash from Discontinued Operations shows a peak YoY surged of 73.66% (in 2017) over the last 5 years.
  • Over the past 3 years, Soleno Therapeutics' Cash from Discontinued Operations (Quarterly) stood at -$1.4 million in 2016, then surged by 59.33% to -$563,000 in 2017, then soared by 66.61% to -$188,000 in 2018.
  • Its last three reported values are -$188,000 in Q4 2018, -$405,000 for Q3 2018, and -$281,000 during Q2 2018.